Breakthrough Antibody Treatment Unleashes Immune System Against Tumors

Researchers at Tel Aviv University have discovered a new method to treat cancer by targeting a protein called Ly6a, which acts as an immune "brake". This protein, found in high levels in tumors, helps cancer evade the immune system. By using anti-Ly6a antibodies to release these brakes, the immune system can effectively attack and reduce tumors, including those resistant to current immunotherapies. The findings, published in Nature Communications, could lead to new treatments for cancer patients who do not respond to existing therapies.